Results 81 to 90 of about 23,287 (168)

Human T-cell Lymphotropic Virus Type 1 (HTLV-1)-Associated Adult T-cell Leukemia/Lymphoma in a Patient Previously Treated for Strongyloidiasis. [PDF]

Cureus, 2023
Basharat A, Anwar MY, Sulh M, Venkatram S, Diaz-Fuentes G.   +4 more
europepmc   +1 more source

Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies. [PDF]

BMC Infect Dis, 2023
Seighali N, Shafiee A, Rafiee MA, Aminzade D, Mozhgani SH.   +4 more
europepmc   +1 more source

Seroprevalence of maternal peripartum human T-cell lymphotropic virus type-1 infection: a systematic review and meta-analysis of the Nigerian literature. [PDF]

Clin Exp Pediatr, 2023
Usman A, Musa MH, Shuaib BI, Balogun O, Adeiza M.   +4 more
europepmc   +1 more source

Correction: Human T-cell lymphotropic virus type 1 transmission dynamics in rural villages in the Democratic Republic of the Congo with high nonhuman primate exposure. [PDF]

PLoS Negl Trop Dis, 2023
Halbrook M, Gadoth A, Shankar A, Zheng H, Campbell EM, Hoff NA, Muyembe JJ, Wemakoy EO, Rimoin AW, Switzer WM.   +9 more
europepmc   +1 more source

Phenotypic and functional analysis of γδ T cells in the pathogenesis of human T-cell lymphotropic virus type 1 infection. [PDF]

Front Immunol, 2022
Ruggieri M, Ducasa N, Juraske C, Polo VG, Berini C, Quiroga MF, Christopoulos P, Minguet S, Biglione M, Schamel WW.   +9 more
europepmc   +1 more source

Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell Transplantation. [PDF]

Transplant Cell Ther, 2022
Gupta VK, El-Jawahri A, Orkev G, Johnson MH, Weinberg J, Goodrich C, Janakiram M, Sloan JM.   +7 more
europepmc   +1 more source

Nonpharmacological interventions and outcomes in the management of complications of human T-cell lymphotropic virus type 1-related myelopathy/tropical spastic paraparesis: A systematic review. [PDF]

J Res Med Sci, 2023
Davoudi M, Boostani R, Manzari ZS.
europepmc   +1 more source

Human T-Cell Lymphotropic Virus Type 1 and Strongyloides stercoralis Co-infection: A Systematic Review and Meta-Analysis. [PDF]

Front Med (Lausanne), 2022
Ye L, Taylor GP, Rosadas C.
europepmc   +1 more source

Cabotegravir, the Long-Acting Integrase Strand Transfer Inhibitor, Potently Inhibits Human T-Cell Lymphotropic Virus Type 1 Transmission in vitro. [PDF]

Front Med (Lausanne), 2022
Schneiderman BS, Barski MS, Maertens GN.
europepmc   +1 more source

Human T-cell lymphotropic virus type 1 (HTLV-1)-associated bronchioloalveolar disorder required differentiation from fibrotic chronic hypersensitivity pneumonitis. [PDF]

Radiol Case Rep, 2022
Chikasue T, Sumi A, Tanoue S, Abe T, Tominaga M, Fukuoka J, Fujimoto K.   +6 more
europepmc   +1 more source